Related references
Note: Only part of the references are listed.Current and future burden of breast cancer: Global statistics for 2020 and 2040
Melina Arnold et al.
BREAST (2022)
BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer
Karolina Prajzendanc et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Evaluation of the BRCAness phenotype and its correlations with clinicopathological features in triple-negative breast cancers
Tian Tian et al.
HUMAN PATHOLOGY (2019)
Evaluation of BRCA1, STAT-1 and STAT-3 expression in non familial breast cancer from North India: An interim analysis.
Sameer Gupta et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Frequent alterations of homologous recombination repair pathway in primary and chemotolerant breast carcinomas: clinical importance
Hemantika Dasgupta et al.
FUTURE ONCOLOGY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
Delay in presentation to the hospital and factors affecting it in breast cancer patients attending tertiary care center in Central India
N. A. Thakur et al.
INDIAN JOURNAL OF CANCER (2015)
Delay in presentation to the hospital and factors affecting it in breast cancer patients attending tertiary care center in Central India
N. A. Thakur et al.
INDIAN JOURNAL OF CANCER (2015)
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
Epigenetic Modifications in Breast Cancer and Their Role in Personalized Medicine
Olafur A. Stefansson et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer
Tarique N. Hasan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression
Amanjit Bal et al.
VIRCHOWS ARCHIV (2012)
BRCA1/BARD1 E3 Ubiquitin Ligase Can Modify Histones H2A and H2B in the Nucleosome Particle
Amit Thakar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2010)
Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours
Darci T. Butcher et al.
EUROPEAN JOURNAL OF CANCER (2007)
BRCA1 gene expression in breast cancer:: A correlative study between real-time RT-PCR and immunohistochemistry
F Al-Mulla et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors
N Chunder et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers
K Miyamoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2002)
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
A Bhattacharyya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
